The abstract is read at the publisher; the summary is JClub's.
Bioengineered efferocytic cell-derived nanovesicles can spatiotemporally regulate neutrophil–macrophage crosstalk, suppress hyperactivated neutrophils, and promote inflammation resolution and tissue repair.
- Why it matters: Current anti-inflammatory drugs show unsatisfactory efficacy and safety, and the mechanisms linking dysregulated neutrophil–macrophage interactions to acute and chronic tissue injury remain insufficiently targeted.
- What they did: The work shows dysregulated Neu–Mac interactions drive inflammation in acute and chronic tissue injury states, then engineers efferocytic Mac-derived artificial nanovesicles (ACDV Effero) and probiotic-derived membrane–enhanced versions (BNV Effero) to increase Neu targeting and payload transfer into Macs.
- The result: Effero-derived vesicles induce an immunoregulatory macrophage phenotype, suppress hyperactivated neutrophils, promote their apoptosis, and—via increased efferocytosis—support a positive loop that advances inflammation resolution and tissue repair.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.